Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment

S Marur, AA Forastiere - Mayo Clinic Proceedings, 2016 - Elsevier
Squamous cell carcinoma arises from multiple anatomic subsites in the head and neck
region. The risk factors for development of cancers of the oral cavity, oropharynx …

Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting

P Economopoulou, R De Bree, I Kotsantis… - Frontiers in …, 2019 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) represents a group of tumors arising in
the oral cavity, oropharynx, and larynx. Although HNSCC is traditionally associated with …

Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology

DG Pfister, S Spencer, D Adelstein, D Adkins… - Journal of the National …, 2020 - jnccn.org
Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment …

Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline

SA Koyfman, N Ismaila, D Crook, A D'Cruz… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE The aim of the current work is to provide evidence-based recommendations to
practicing physicians and others on the management of the neck in patients with squamous …

Emerging biomarkers in head and neck cancer in the era of genomics

H Kang, A Kiess, CH Chung - Nature reviews Clinical oncology, 2015 - nature.com
Head and neck cancer (HNC) broadly includes carcinomas arising from the mucosal
epithelia of the head and neck region as well as various cell types of salivary glands and the …

Head and neck cancers, version 2.2014

DG Pfister, S Spencer, DM Brizel, B Burtness… - Journal of the National …, 2014 - jnccn.org
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Head and Neck Cancers focuses on glottic laryngeal cancer, which is the most common …

Positron-emission tomography and assessment of cancer therapy

ME Juweid, BD Cheson - New England Journal of Medicine, 2006 - Mass Medical Soc
Positron-Emission Tomography and Assessment of Cancer Therapy | New England Journal of
Medicine Skip to main content Access provided byTE WHATU ORA HEALTH NEW ZEALAND …

Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis

T Gupta, Z Master, S Kannan, JP Agarwal… - European journal of …, 2011 - Springer
Purpose Our objective was to conduct a systematic review and meta-analysis of studies
assessing the diagnostic performance of 18 F-fluorodeoxyglucose positron emission …

FDG-PET/CT pitfalls in oncological head and neck imaging

BS Purohit, A Ailianou, N Dulguerov, CD Becker… - Insights into …, 2014 - Springer
Objectives Positron emission tomography-computed tomography (PET/CT) with fluorine-18-
fluorodeoxy-D-glucose (FDG) has evolved from a research modality to an invaluable tool in …

Clinical practice in PET/CT for the management of head and neck squamous cell cancer

R Goel, W Moore, B Sumer, S Khan… - American Journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to summarize the evidence for the value of
PET/CT for the management of patients with head and neck squamous cell cancer and …